€ 4.05
Key Takeaways
Risk factor
Very poor trading liquidity
Profitability factor
Very low or no dividends
About
Optomed Oyj, a medical technology company, manufactures and sells handheld fundus cameras and screening software in Finland, China, and internationally. The company operates through two segments, Devices and Software segments. The company develops, manufactures, and sells fundus camera products, which are used by ophthalmologists, pediatricians, endocrinologists, neurologists, and primary care professionals. It offers camera products...
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks.
Target Price
The average target price of OPTOMED.HE is 4.9 and suggests 21% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i
